Study reveals weight loss medications may improve outcomes for chronic sinus disease patients

A new study published in Otolaryngology–Head and Neck Surgery reveals that glucagon-like peptide-1 receptor agonists ...
CNN

More people with type 1 diabetes are using GLP-1 drugs, study finds, despite limited evidence on safety or effectiveness

The use of drugs like Ozempic, Wegovy and Zepbound in people with type 1 diabetes has risen sharply over the past decade, a new study finds, even though there’s little information on the drugs’ safety ...

Viking Therapeutics Announces Publication of Results from Phase 2 VENTURE Trial of Dual GLP-1/GIP Receptor Agonist VK2735 in the Journal Obesity

The paper, titled, "Weekly Subcutaneous VK2735, a GIP/GLP-1 Receptor Dual Agonist, for Weight Management: Phase 2, Randomized, 13-Week VENTURE Study," was published in Obesity, the peer-reviewed ...
KFF Health News on MSN

Physician-Journalist Shines Light on Measles Upsurge and New GLP-1 Study

KFF Health News' editor-at-large for public health recently took to the airwaves to discuss topical stories. Here’s a ...